Open AccessCritical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines
Author(s) -
Alhmoud Eman N.,
Barazi Raja,
Fahmi Amr,
Abdu Abdullah,
Higazy Alya,
ElHajj Maguy
Publication year - 2020
Publication title -
journal of pharmaceutical health services research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.244
H-Index - 15
eISSN - 1759-8893
pISSN - 1759-8885
DOI - 10.1111/jphs.12371
Subject(s) - medicine , rigour , guideline , clinical practice , canadian cardiovascular society , intensive care medicine , family medicine , pathology , myocardial infarction , geometry , mathematics , angina
Objective The aim of the study was to assess the quality of the recently published European clinical practice guidelines for the management of dyslipidaemias, utilizing the refined Appraisal of Guidelines for Research & Evaluation tool. Method The 2019 European Society of Cardiology and European Atherosclerosis Society Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk was appraised and scored for methodological rigour and transparency by 5 independent appraisers using a validated tool. Key findings The guideline scored highest in the domains that evaluated editorial independence (100%) and clarity of presentation (98.6%) and lowest in the domains that addressed stakeholder involvement (55.56%) and rigour of development (63%). Overall the quality of the guideline was high, and all reviewers recommended its use in practice. Conclusion The guideline’s overall quality was judged to be high, and all appraisers recommended its use in practice without modifications.